Conexeu Sciences Inc. Common Stock

CNXU· NASDAQ· Health Care

$2.83-1.74%

2026-10-29

Valuation Metrics

Conexeu Sciences Inc. Common Stock's Market Cap is $76M. Ranked #3069 of 3,115 in US market (top 99%), #1432 of 1,472 on NASDAQ (top 97%) by Market Cap.

Investment Metrics(as of 2026-10-29)

Metric	Value	Rank
Size
Market Cap	$76M	US#3,069/3,115
Employees	4	US#2,788/3,115
Performance
1M Return	-23.72%	US#2,960/3,115
From 52W High	-83.24%	US#3,073/3,115
1Y MDD	-81.47%	US#3,050/3,115
Trading
Volume	411,430 shares	US#2,342/3,115
Trading Value	$1M	US#3,021/3,115

Company Info

CEO Miles Harrison

Employees 4

HQ Reno, US

Website www.conexeu.com

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.